Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Protein Page:
LRIG1 (human)
p Phosphorylation
a Acetylation
m Methylation
m1 Mono-methylation
m2 Di-methylation
m3 Tri-methylation
u Ubiquitination
s Sumoylation
n Neddylation
gl O-GlcNAc
ga O-GalNAc
h Palmitoylation
ad Adenylylation
sn S-Nitrosylation
ca Caspase cleavage

Overview
LRIG1 a singhle-pass type I membrane protein that acts as a feedback negative regulator of signaling by receptor tyrosine kinases. Regulates cadherin-dependent contact inhibition. Interacts with EGFR, HER2, -3, and -4. Two isoforms of the human protein are produced by alternative splicing. Note: This description may include information from UniProtKB.
Protein type: Membrane protein, integral; Protein kinase, regulatory subunit
Cellular Component: integral to membrane
Reference #:  Q96JA1 (UniProtKB)
Alt. Names/Synonyms: DKFZp586O1624; leucine-rich repeat protein LRIG1; leucine-rich repeats and immunoglobulin-like domains 1; Leucine-rich repeats and immunoglobulin-like domains protein 1; LIG-1; LIG1; LRIG1; ortholog of mouse integral membrane glycoprotein LIG-1
Gene Symbols: LRIG1
Molecular weight: 119,113 Da
Basal Isoelectric point: 6.66  Predict pI for various phosphorylation states
Protein-Specific Antibodies or siRNAs from Cell Signaling Technology® Total Proteins
Select Structure to View Below

LRIG1

Protein Structure Not Found.


STRING  |  Scansite  |  Phospho.ELM  |  NetworKIN  |  Pfam  |  Source  |  GeneCards  |  UniProtKB  |  Entrez-Gene  |  GenPept  |  Ensembl Gene


Modification Sites and Domains Show Modification Legend
Click here to view phosphorylation modifications only

Modification Sites in Parent Protein, Orthologs, and Isoforms Show Modification Legend
 

Show Multiple Sequence Alignment


 SS 

SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


 MS 

MS: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


       human

 
0 4 S259-p DGAFWGLsKMHVLHL
0 2 T594-p YSHKARLtVNVLPSF
0 1 T623-ga ARLECAAtGHPNPQI
0 17 Y941-p CNTEVDCySRGQAFH
0 3 Y996-p PECQGSLyPSNHDRM
0 2 Y1029-p SWTLARLyHPDSTEL
0 21 Y1054-p PERAEAQyLLVSNGH
  mouse

 
S261 DGAFWGLSKMHVLHL
T596-p YSHKARLtVNVLPSF
T625 ARLECAATGHPNPQI
Y940 DCSTDTAYHPQPVPR
Y989 TLSGGSLYPSNHDRI
H1021 SWTLAKLHEADCIDL
H1052 AISTEAQHLLVSNGH
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.